The Economic, Medical and Psychosocial Consequences of Whole Genome Sequencing for the Genetic Diagnosis of Patients With Intellectual Disability: The DEFIDIAG Study Protocol

被引:0
作者
Lejeune, Catherine [1 ,2 ]
Robert-Viard, Charley [1 ,3 ]
Meunier-Beillard, Nicolas [1 ,3 ]
Borel, Myriam Alice [4 ]
Gourves, Lena [5 ]
Staraci, Stephanie [6 ]
Soilly, Anne-Laure [3 ]
Guillemin, Francis [7 ]
Seror, Valerie [8 ]
Achit, Hamza [7 ]
Bouctot, Marion [1 ]
Asensio, Marie-Laure [1 ]
Briffaut, Anne-Sophie [1 ]
Delmas, Christelle [9 ]
Bruel, Ange-Line [10 ]
Benoit, Alexia [11 ]
Simon, Alban [12 ]
Gerard, Benedicte [11 ]
Hadj Abdallah, Hamza [13 ,14 ]
Lyonnet, Stanislas [13 ,14 ]
Faivre, Laurence [10 ]
Thauvin-Robinet, Christel [10 ]
Odent, Sylvie [15 ]
Heron, Delphine [6 ]
Sanlaville, Damien [16 ]
Frebourg, Thierry [17 ,18 ]
Muller, Jean [11 ,12 ,19 ]
Duffourd, Yannis [10 ]
Boland, Anne [20 ]
Deleuze, Jean-Francois [20 ]
Esperou, Helene [9 ]
Binquet, Christine [1 ]
Dollfus, Helene [12 ]
机构
[1] Univ Bourgogne, CHU Dijon Bourgogne, Inserm, CIC 1432, Dijon, France
[2] Univ Bourgogne Franche Comte, Inserm, UMR 1231, EPICAD, Dijon, France
[3] CHU Dijon Bourgogne, Delegat RechercheClin & Innovat, USMR, Dijon, France
[4] Observ Reg St Bourgogne Franche Comte, Dijon, France
[5] CHU Dijon Bourgogne, Direct Rech Clin, Dijon, France
[6] APHP Sorbonne Univ, Un Fonct Genet Medicale & Centrede Reference Defic, Grp Hosp Pitie Salpetriere, Hopital Trousseau, Paris, France
[7] Univ Lorraine, Ctr Hospitalier Reg & Univ, Epidemiol Clin CIC1433, Inserm, Nancy, France
[8] Aix Marseille Univ, IRD, APHM, SSA,IHU Mediterranee Infect,VITROME, Marseille, France
[9] Inserm, Pole Rech Clin, Paris, France
[10] Univ Bourgogne Franche Comte, Equipe GAD, CHU Dijon Bourgogne, Federat Hosp Univ Med Translat & Anomalies Dev TRA, Dijon, France
[11] Hop Univ Strasbourg, Inst Genet Medicale Alsace IGMA, Labs Diagnost Genet, Strasbourg, France
[12] Univ Strasbourg, France & Serv Genet Med Hop Univ Strasbourg, Inst Genet Medicale Alsace, Inserm UMRS 1112, Strasbourg, France
[13] Univ Paris Cite, IHUI magine Inst Malad Genet, Inserm, Paris, France
[14] Ctr Univ Paris Cite, Hop Necker Enfants Malad, GHU APHP, Federat Genet Med Genomique, Paris, France
[15] Univ Rennes, Inst Genet & Dev Rennes, Ctr Reference Anomalies Dev CLAD Ouest, Serv Genet Clin,CNRS,IGDR UMR6290,ERN ITHACA, Rennes, France
[16] Univ Claude Bernard Lyon 1, Serv Genet, Hosp Civils Lyon, GHE, Lyon, France
[17] CHU Rouen, Serv Genet, Rouen, France
[18] Univ Normandie, Ctr Genomique & Medecine Personnalisee, Inserm, UMR1245, Rouen, France
[19] Hop Univ Strasbourg, UniteFonct Bioinformat Med Appliquee Diagnost UF73, Strasbourg, France
[20] Univ Paris Saclay, Ctr Natl Rech Genomique Humaine CNRGH, CEA, Evry, France
关键词
intellectual disability; genome sequencing; cost-effectiveness; qualitative study; micro-costing; UTILITY;
D O I
10.3389/fgene.2022.852472
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Like other countries, France has invested in a national medical genomics program. Among the four pilot research studies, the DEFIDIAG project focuses on the use of whole genome sequencing (WGS) for patients with intellectual disability (ID), a neurodevelopmental condition affecting 1-3% of the general population but due to a plethora of genes. However, the access to genomic analyses has many potential individual and societal issues in addition to the technical challenges. In order to help decision-makers optimally introduce genomic testing in France, there is a need to identify the socio-economic obstacles and leverages associated with the implementation of WGS.Methods and Analysis: This humanities and social sciences analysis is part of the DEFIDIAG study. The main goal of DEFIDIAG is to compare the percentage of causal genetic diagnoses obtained by trio WGS (including the patient and both parents) (WGS(T)) to the percentage obtained using the minimal reference strategy currently used in France (Fragile-X testing, chromosomal microarray analysis, and gene panel strategy including 44 ID genes) for patients with ID having their first clinical genetics consultation. Additionally, four complementary studies will be conducted. First, a cost-effectiveness analysis will be undertaken in a subsample of 196 patients consulting for the first time for a genetic evaluation; in a blinded fashion, WGS(T) and solo (index case, only) genomic analysis (WGS(S)) will be compared to the reference strategy. In addition, quantitative studies will be conducted: the first will estimate the cost of the diagnostic odyssey that could potentially be avoidable with first-line WGS(T) in all patients previously investigated in the DEFIDIAG study; the second will estimate changes in follow-up of the patients in the year after the return of the WGS(T) analysis compared to the period before inclusion. Finally, through semi-directive interviews, we will explore the expectations of 60 parents regarding genomic analyses.Discussion: Humanities and social sciences studies can be used to demonstrate the efficiency of WGS and assess the value that families associate with sequencing. These studies are thus expected to clarify trade-offs and to help optimize the implementation of genomic sequencing in France.Ethics Statement: The protocol was approved by the Ethics Committee Sud Mediterranee I (June 2019)-identification number: 2018-A00680-55 and the French data privacy commission (CNIL, authorization 919361).& nbsp;
引用
收藏
页数:11
相关论文
共 29 条
  • [1] Adithyan G., 2017, Disability, CBR Inclusive Development, V28, P74, DOI [DOI 10.5463/DCID.V28I2.595, 10.5463/dcid.v28i2.595]
  • [2] Aviesan, FRANC MDEC GNOM
  • [3] Genome Sequencing for Genetics Diagnosis of Patients With Intellectual Disability: The DEFIDIAG Study
    Binquet, Christine
    Lejeune, Catherine
    Faivre, Laurence
    Bouctot, Marion
    Asensio, Marie-Laure
    Simon, Alban
    Deleuze, Jean-Francois
    Boland, Anne
    Guillemin, Francis
    Seror, Valerie
    Delmas, Christelle
    Esperou, Helene
    Duffourd, Yannis
    Lyonnet, Stanislas
    Odent, Sylvie
    Heron, Delphine
    Sanlaville, Damien
    Frebourg, Thierry
    Gerard, Benedicte
    Dollfus, Helene
    [J]. FRONTIERS IN GENETICS, 2022, 12
  • [4] Methods in health service research - Handling uncertainty in economic evaluations of healthcare interventions
    Briggs, AH
    Gray, AM
    [J]. BRITISH MEDICAL JOURNAL, 1999, 319 (7210) : 635 - 638
  • [5] Buntinx W., 2016, DEFICIENCES INTELLEC
  • [6] Using medical exome sequencing to identify the causes of neurodevelopmental disorders: Experience of 2 clinical units and 216 patients
    Cherot, E.
    Keren, B.
    Dubourg, C.
    Carre, W.
    Fradin, M.
    Lavillaureix, A.
    Afenjar, A.
    Burglen, L.
    Whalen, S.
    Charles, P.
    Marey, I.
    Heide, S.
    Jacquette, A.
    Heron, D.
    Doummar, D.
    Rodriguez, D.
    de Villemeur, T. Billette
    Moutard, M. -L.
    Guet, A.
    Xavier, J.
    Perisse, D.
    Cohen, D.
    Demurger, F.
    Quelin, C.
    Depienne, C.
    Odent, S.
    Nava, C.
    David, V.
    Pasquier, L.
    Mignot, C.
    [J]. CLINICAL GENETICS, 2018, 93 (03) : 567 - 576
  • [7] The human genome project: Lessons from large-scale biology
    Collins, FS
    Morgan, M
    Patrinos, A
    [J]. SCIENCE, 2003, 300 (5617) : 286 - 290
  • [8] Consortium YHE, 2016, NET MON BEN
  • [9] Evaluating the utility of personal genomic information
    Foster, Morris W.
    Mulvihill, John J.
    Sharp, Richard R.
    [J]. GENETICS IN MEDICINE, 2009, 11 (08) : 570 - 574
  • [10] Microcosting Quantity Data Collection Methods
    Frick, Kevin D.
    [J]. MEDICAL CARE, 2009, 47 (07) : S76 - S81